Showing results (51-60 of 158) with videos related to
Sort By:
Pageof 16
The American Journal of Medicine|September 4, 2012
Incidence of thrombocytopenia among patients receiving heparin venous thromboembolism prophylaxisTracy Y Wang, Emily F Honeycutt, Victor F Tapson, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 20, 2013
One-year experience with intravenous treprostinil for pulmonary arterial hypertensionRaymond L Benza, Victor F Tapson, Mardi Gomberg-Maitland, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 7, 2007
Creation of a model comparing 6-minute walk test to metabolic equivalent in evaluating treatment effects in pulmonary arterial hypertensionMardi Gomberg-Maitland, Dezheng Huo, Raymond L Benza, et al.Chest|January 18, 2002
Outcome of lung transplantation in patients with mycetomasDenis Hadjiliadis, Thomas A Sporn, John R Perfect, et al.Thrombosis and Haemostasis|February 16, 2005
Gender differences in the administration of prophylaxis to prevent deep venous thrombosisNils Kucher, Victor F Tapson, Rene Quiroz, et al.Journal of Thrombosis and Thrombolysis|April 9, 2021
Direct oral anticoagulants in chronic thromboembolic pulmonary hypertensionMateo Porres-Aguilar, Marius M Hoeper, Belinda N Rivera-Lebron, et al.Journal of the American College of Cardiology|June 15, 2004
End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectivesMarius M Hoeper, Ronald J Oudiz, Andrew Peacock, et al.Scientific Reports|March 13, 2019
Clinical Features and Outcomes of Patients with Sarcoidosis-associated Pulmonary HypertensionKishan S Parikh, Talal Dahhan, Leigh Nicholl, et al.Cardiovascular Ultrasound|October 30, 2016
Clinical and echocardiographic predictors of mortality in acute pulmonary embolismTalal Dahhan, Irfan Siddiqui, Victor F Tapson, et al.Chest|March 16, 2006
Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: a prospective, multicenter, open-label, 12-week trialVictor F Tapson, Mardi Gomberg-Maitland, Vallerie V McLaughlin, et al.Pageof 16